Gilead Sciences Reports Q2 2024 Financial Results

Gilead Sciences Announces Second Quarter 2024 Financial Results

Gilead Sciences Announces Second Quarter 2024 Financial Results · Product gross margin was 77.7% in the second quarter 2024, compared to 78.0% in ...

Gilead Sciences to Release Second Quarter 2024 Financial Results ...

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its second quarter 2024 financial results ...

Financials - Quarterly Results - Gilead Sciences, Inc.

Q2 2024. Q1 2024. Q4 2023. Select quarter: Q3 2024, Q2 2024, Q1 2024, Q4 2023 ... Q1 Q1 Financial Statement not available Q2 Q2 Financial Statement not ...

Gilead Sciences Announces Second Quarter 2024 Financial Results

FOSTER CITY, Calif. --(BUSINESS WIRE)--Aug. 8, 2024-- Gilead Sciences , Inc. (Nasdaq: GILD) announced today its second quarter 2024 results of ...

Gilead Sciences reports net income rise in Q2 2024

Gilead Sciences has reported net income attributable to the company at $1.61bn, up from $1.04bn in the corresponding quarter of 2023.

Gilead Sciences Reports Q2 2024 Financial Results

Gilead Sciences, Inc. announced its financial results for the second quarter of 2024, showcasing a 5% revenue increase to $7.0 billion ...

Gilead Sciences Announces Third Quarter 2024 Financial Results

Total third quarter 2024 revenue increased 7% to $7.5 billion compared to the same period in 2023, primarily due to higher sales in HIV as well ...

Events & Presentations - Gilead Sciences, Inc. - Investor Relations

Q324 Financial Results ... Wells Fargo Healthcare Conference · Webcast(opens in new window). Aug 8th, 2024 | 4:30 PM ET. Gilead Sciences Q2 2024 Earnings ...

Gilead Sciences Second Quarter 2024 Earnings: Beats Expectations

Gilead Sciences ( NASDAQ:GILD ) Second Quarter 2024 Results Key Financial Results Revenue: US$6.95b (up 5.4% from 2Q...

Gilead Sciences Q2 2024 Financial Results - TradingView

Financial Highlights. For the second quarter of 2024, Gilead Sciences reported a total revenue increase of 5% year-over-year, reaching $7.0 ...

Gilead Sciences posts higher Q2 profit and revenue on increased ...

The Foster City, Calif., biopharmaceutical company on Thursday reported second-quarter net income of $1.61 billion, $1.29 a share, up from $1.05 billion, or 83 ...

Gilead Sciences' Q2 2024 Earnings: What To Expect - Barchart.com

For fiscal 2024, analysts expect GILD to report EPS of $3.71, down 44.8% from $6.72 in fiscal 2023. However, EPS is expected to increase 94.6% ...

Gilead Sciences Inc (GILD) Q2 2024 Earnings Call Highlights

Gilead Sciences Inc (GILD) reports robust financial performance with significant sales growth in key therapeutic areas and raises full-year ...

GILEAD SCIENCES ANNOUNCES SECOND QUARTER 2024 ...

Total second quarter 2024 revenue increased 5% to $7.0 billion, compared to the same period in 2023, primarily due to higher product sales in ...

Gilead Stock Dips As 'Non-Core' Products Drive Its Second-Quarter ...

The company boosted its adjusted earnings outlook by 10 cents at the midpoint to $3.60 to $3.90 per share. The Street called for $3.76. Gilead ...

Gilead Sciences reports higher Q2 revenue and profit - AlphaStreet

Earnings Summary: Gilead Sciences reports higher Q2 revenue and profit · Second-quarter revenue increased 5% from last year to $7.0 billion, ...

Gilead Sciences (GILD) Q2 2024 Earnings: EPS of $1.29 Beats Esti

Gilead Sciences Inc (GILD, Financial) reported a total revenue increase of 5% year-over-year to $7.0 billion, surpassing the analyst estimate of $6.98 billion.

Financials - SEC Filings - Gilead Sciences, Inc. - Investor Relations

Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other

Gilead quarterly profit beats Street estimates, revenue up 5% - Reuters

Gilead Sciences on Thursday reported second-quarter profit that ... For full-year 2024, Gilead said it still expects product sales of ...

GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue ...

GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q2 2024 · Gilead Sciences reported earnings per share of $2.01. This was above ...